Observational studyKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2026
Individualised total knee arthroplasty demonstrates 99.4% survival at 3 to 5 years.
Observational study in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe purpose of this multicentre observational study is to evaluate implant survival and patient-reported outcome measures (PROMs) at 3-5 years following individualised total knee arthroplasty (TKA).
methodsA consecutive series of 426 patients (434 knees) underwent CT-based, posterior-stabilised, cemented, individualised TKA between December 2018 and August 2020. After excluding 73 patients without informed consent, 353 patients (361 knees) were included for survival analysis. A further 74 were excluded (revised = 2, deceased = 11, inadequate follow-up = 61), resulting in a final cohort of 279 patients (287 knees) for PROMs assessment. Implant survival was evaluated using the Kaplan-Meier (KM) method, with revision of any component for any reason as the endpoint at 2- and 3-year follow-ups. Patients completed pre and postoperative questionnaires of the Oxford knee score (OKS) and the forgotten joint score (FJS), and also rated their level of satisfaction on a 4-level Likert scale. The proportion of patients who achieved a patient acceptable symptom state (PASS) was estimated according to the threshold of 30 for OKS and 38 for FJS.
resultsConsidering revision for any reason as endpoint, the survival according to the KM method was 99.4% (95% confidence interval [CI] 98.6%-100.0%) at both 2- and 3-year follow-up. The OKS improved from 22.2 ± 8.4 to 40.6 ± 7.6, and 244 knees (85%) achieved the PASS. The FJS improved from 16.7 ± 14.6 to 68.5 ± 27.7, and 233 (81%) achieved the PASS. Out of the 254 knees with their rated level of satisfaction, 250 (98.4%) were either satisfied or very satisfied.
conclusionAt 3 to 5 years' follow-up, individualised TKA demonstrated excellent implant survival (99.4%), as well as high patient satisfaction, both considering and disregarding non-respondents (87.1% and 98.4% respectively). The results are promising and warrant continued follow-up to evaluate long-term results. LEVEL OF EVIDENCE: Level IV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.